The CDC reported recently that the percentage of privately insured reproductive-age women who filled a prescription for a medication for attention-deficit/hyperactivity disorder (ADHD) soared 344% from 2003 (0.9%) to 2015 (4.0%).
The CDC reported recently that the percentage of privately insured reproductive-age women who filled a prescription for a medication for attention-deficit/hyperactivity disorder (ADHD) soared 344% from 2003 (0.9%) to 2015 (4.0%).
ADHD medication prescriptions increased across all ages and US geographic regions. The increase was confined to stimulant medications.
CDC shared additional research on ADHD medication safety, including before and during pregnancy, which could help women and their healthcare providers make evidence-based decisions concerning the risks and benefits of treatment.
This is the second time the CDC has warned women to be careful of what they ingest on the chance that they become pregnant without knowing it. Two years ago, they warned women of childbearing age about the risks of drinking in case they become pregnant.
The CDC used the Truven Health MarketScan Commercial Database for the period 2003-2015 to estimate the percentage of women aged 15-44 years with private employer-sponsored insurance who filled ADHD prescriptions.
The percentage of reproductive-age women who filled at least 1 ADHD medication prescription increased 344% from 2003 (0.9% of women) to 2015 (4.0% of women). In 2015, the most frequently filled medications were mixed amphetamine salts, lisdexamfetamine, and methylphenidate.
From 2003 to 2015, the largest increase (700%) in ADHD prescriptions filled occurred among women aged 25-29 years.
In 2015, the highest percentage of ADHD medication prescriptions were filled by women in the South (4.8%) and North Central (4.0%) US regions.
The largest increase from 2003 to 2015 occurred in the South (380%).
This study did not include women on Medicaid or women who paid out-of-pocket for prescriptions. The study also did not identify a woman’s pregnancy status.
Reference
Centers for Disease Control and Prevention. Attention-deficit/hyperactivity disorder medication prescription claims among privately insured women aged 15—44 Years—United States, 2003-2015. CDC website. cdc.gov/mmwr/volumes/67/wr/mm6702a3.htm?s_cid=mm6702a3_e#suggestedcitation. Published January 18, 2018. Accessed January 22, 2018.
Congress Urged to Repeal Comstock Act Threatening Reproductive Rights and Public Health
May 16th 2024In a joint letter addressed to Congress, Healthcare Across Borders, Take Back the Court Action Fund, and UltraViolet Action called out the resurgence of the Comstock Act, urging immediate action to repeal this century-old law that threatens reproductive rights and public health in the US.
Read More
Addressing Maternal Mortality in Medicaid by Focusing on Mental Health
February 15th 2023On this episode of Managed Care Cast, we speak with Inland Empire Health Plan, a managed care plan serving more than 1.4 million residents on Medi-Cal in California, about a new maternal mental health program aimed at supporting new mothers, both before they give birth and afterward.
Listen
Shelly Lanning on How Employers Can Reduce Costs by Bridging Gaps in Women's Health Care
May 3rd 2024In a presentation at the Greater Philadelphia Business Coalition on Health Women’s Health Summit, Shelly Lanning, cofounder and president of Visana Health, addressed the need for comprehensive approaches in women’s health care and their coverage options.
Read More
For National Women’s Health Week, One Company Emphasizes Cardiovascular Risk Management
May 10th 2022On this episode of Managed Care Cast, we speak with Joanne Armstrong, MD, MPH, vice president and chief medical officer for Women’s Health and Genomics at CVS Health, on the distinct pathophysiology of cardiovascular disease in women and how her own health experiences have influenced her perspective on cardiovascular disease management.
Listen
The HHS Office for Civil Rights is investigating whether patient data were exposed in the cyberattack on Change Healthcare; a new study claims that the US’ high maternal mortality rates are the product of flawed data; HHS secretary is open to drug testing recipients of welfare.
Read More